Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhansheng Jiang

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 24, 2017
[Progress of PD-1/PD-L1 Inhibitors in Non-small Cell Lung Cancer]Zhansheng Jiang, Zhanyu Pan, Xiubao Ren
Cancer Immunology, Immunotherapy : CII|June 25, 2020
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancerYinli Yang, Ling Li, Zhansheng Jiang, et al.
Zhonghua Yi Xue Za Zhi|January 28, 2015
[Efficacy of lapatinib versus trastuzumab in neoadjuvant therapy of HER-2 positive breast cancer: a meta-analysis]Zhansheng Jiang, Yanfang Yang, Zhanyu Pan, et al.
Thoracic Cancer|July 21, 2018
Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non-T790M mutations after progression on first-line EGFR-tyrosine kinase inhibitorsZhansheng Jiang, Yu Zhang, Yinli Yang, et al.
The Breast Journal|April 25, 2018
A case of tonsillar metastasis from breast cancer and literature reviewZhansheng Jiang, Yanfang Yang, Shuai Li, et al.
Translational Lung Cancer Research|September 15, 2025
<i>STK11</i>/<i>KEAP1</i> co-mutations in <i>SMARCA4</i>-mutant advanced non-small cell lung cancer: genetic characteristics and impact on immunotherapy efficacyZiyi Dong, Ran Zuo, Yaoyang Guo, et al.
Gynecologic Oncology|May 2, 2024
Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancerZhansheng Jiang, Mingyu Zhu, Lu Zhang, et al.
Journal of Cancer Research and Therapeutics|December 13, 2018
Capecitabine monotherapy in advanced breast cancer resistant to anthracycline and taxane: A meta-analysisZhansheng Jiang, Yanfang Yang, Ling Li, et al.
Chemistry & Biodiversity|November 5, 2025
Cytotoxic Chaetoglobosins From a Soil-derived Chaetomium spJie Xu, Yanfang Yang, Qianqian Li, et al.
Hereditas|December 13, 2025
LINC01980 promotes the malignant progression of lung squamous carcinoma by targeting miR-204-3pMan Zhang, Weiwei Sun, Zhansheng Jiang, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 24, 2017
[Progress of PD-1/PD-L1 Inhibitors in Non-small Cell Lung Cancer]Zhansheng Jiang, Zhanyu Pan, Xiubao Ren
Cancer Immunology, Immunotherapy : CII|June 25, 2020
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancerYinli Yang, Ling Li, Zhansheng Jiang, et al.
Zhonghua Yi Xue Za Zhi|January 28, 2015
[Efficacy of lapatinib versus trastuzumab in neoadjuvant therapy of HER-2 positive breast cancer: a meta-analysis]Zhansheng Jiang, Yanfang Yang, Zhanyu Pan, et al.
Thoracic Cancer|July 21, 2018
Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non-T790M mutations after progression on first-line EGFR-tyrosine kinase inhibitorsZhansheng Jiang, Yu Zhang, Yinli Yang, et al.
The Breast Journal|April 25, 2018
A case of tonsillar metastasis from breast cancer and literature reviewZhansheng Jiang, Yanfang Yang, Shuai Li, et al.
Translational Lung Cancer Research|September 15, 2025
<i>STK11</i>/<i>KEAP1</i> co-mutations in <i>SMARCA4</i>-mutant advanced non-small cell lung cancer: genetic characteristics and impact on immunotherapy efficacyZiyi Dong, Ran Zuo, Yaoyang Guo, et al.
Gynecologic Oncology|May 2, 2024
Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancerZhansheng Jiang, Mingyu Zhu, Lu Zhang, et al.
Journal of Cancer Research and Therapeutics|December 13, 2018
Capecitabine monotherapy in advanced breast cancer resistant to anthracycline and taxane: A meta-analysisZhansheng Jiang, Yanfang Yang, Ling Li, et al.
Chemistry & Biodiversity|November 5, 2025
Cytotoxic Chaetoglobosins From a Soil-derived Chaetomium spJie Xu, Yanfang Yang, Qianqian Li, et al.
Hereditas|December 13, 2025
LINC01980 promotes the malignant progression of lung squamous carcinoma by targeting miR-204-3pMan Zhang, Weiwei Sun, Zhansheng Jiang, et al.
Pageof 6